Skip to main content
Top
Published in: Journal of Assisted Reproduction and Genetics 10/2017

01-10-2017 | Assisted Reproduction Technologies

Follicular sensitivity index (FSI): a novel tool to predict clinical pregnancy rate in IVF/ICSI cycles

Authors: AbdelGany M. A. Hassan, Mohamed M. M. Kotb, Ahmed M. A. AwadAllah, Nesreen A. A. Shehata, Amr Wahba

Published in: Journal of Assisted Reproduction and Genetics | Issue 10/2017

Login to get access

Abstract

Purpose

This study aims to introduce a new tool (the Follicular Sensitivity Index; FSI) for objective assessment of follicular responsiveness to exogenous gonadotropins and to evaluate its ability to predict the clinical pregnancy rate in women with unexplained infertility or tubal factor undergoing IVF/ICSI.

Methods

FSI was calculated as preovulatory follicle count (PFC) × 100,000/[antral follicle count (AFC) × total received FSH doses]. One thousand women were included and were divided according to the FSI tertile values into three groups. The primary outcome was clinical pregnancy defined by the presence of an intrauterine gestational sac 5 weeks after embryo transfer.

Results

There was progressive increase in the clinical pregnancy rate from the low to the high FSI groups (0.27 ± 0.4 vs 0.4 ± 0.4 and 0.58 ± 0.4; p < 0.001). Receiver operator curves showed that FSI had a greater area under the curve than those of the AFC, PFC, and the FSH dose (0.638 vs 0.509, 0.538, and 0.589 respectively). Multivariate logistic regression analysis showed that the correlation between FSI and pregnancy was independent of potential confounding factors like age and body mass index (p < 0.001).

Conclusion

FSI can predict the clinical pregnancy rate in women with unexplained infertility or tubal factor undergoing IVF/ICSI using GnRH agonist protocol. Higher FSI values had significantly higher oocyte yield and fertilization and clinical pregnancy rates. Wider implications of these findings include the potential use of FSI to define absolute criteria of poor/good ovarian response in IVF/ICSI cycles, guide future IVF cycle management for the same couples, and guide cycle cancelation criteria for poor ovarian response.
Literature
1.
go back to reference Decleer W, Osmanagaoglu K, Meganck G, Devroey P. A new approach for ovarian stimulation in IVF using Corifollitropin alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study. Facts Views Vis Obgyn. 2014;6:159–65.PubMedPubMedCentral Decleer W, Osmanagaoglu K, Meganck G, Devroey P. A new approach for ovarian stimulation in IVF using Corifollitropin alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study. Facts Views Vis Obgyn. 2014;6:159–65.PubMedPubMedCentral
2.
go back to reference Arce JC, Andersen AN, Fernández-sánchez M, Visnova H, Bosch E, García-Velasco JA, et al. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2014;102:1633–40.e5.CrossRefPubMed Arce JC, Andersen AN, Fernández-sánchez M, Visnova H, Bosch E, García-Velasco JA, et al. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2014;102:1633–40.e5.CrossRefPubMed
3.
go back to reference Broer SL, Van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. IMPORT study group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.CrossRefPubMed Broer SL, Van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. IMPORT study group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.CrossRefPubMed
4.
go back to reference Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718.CrossRefPubMed Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718.CrossRefPubMed
5.
go back to reference Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–55.CrossRefPubMed Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–55.CrossRefPubMed
6.
go back to reference Gallot V, Berwanger da Silva AL, Genro V, Grynberg M, Frydman N, Fanchin R. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the follicular output rate (FORT) may predict in vitro fertilization-embryo transfer outcome. Hum Reprod. 2012;27:1066–72.CrossRefPubMed Gallot V, Berwanger da Silva AL, Genro V, Grynberg M, Frydman N, Fanchin R. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the follicular output rate (FORT) may predict in vitro fertilization-embryo transfer outcome. Hum Reprod. 2012;27:1066–72.CrossRefPubMed
7.
go back to reference Genro VK, Grynberg M, Scheffer JB, Roux I, Frydman R, Fanchin R. Serum anti-Müllerian hormone levels are negatively related to follicular output rate (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Hum Reprod. 2011;26:671–7.CrossRefPubMed Genro VK, Grynberg M, Scheffer JB, Roux I, Frydman R, Fanchin R. Serum anti-Müllerian hormone levels are negatively related to follicular output rate (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Hum Reprod. 2011;26:671–7.CrossRefPubMed
8.
go back to reference Biasoni V, Patriarca A, Dalmasso P, et al. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol. 2011;9:112.CrossRefPubMedPubMedCentral Biasoni V, Patriarca A, Dalmasso P, et al. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol. 2011;9:112.CrossRefPubMedPubMedCentral
9.
go back to reference Zhang N, Hao CF, Zhuang LL, Liu XY, Gu HF, Liu S, et al. Prediction of IVF/ICSI outcome based on the follicular output rate. Reprod BioMed Online. 2013;27:147–53.CrossRefPubMed Zhang N, Hao CF, Zhuang LL, Liu XY, Gu HF, Liu S, et al. Prediction of IVF/ICSI outcome based on the follicular output rate. Reprod BioMed Online. 2013;27:147–53.CrossRefPubMed
10.
go back to reference Hassan A, Kotb M, Awadallah A, Wahba A, Shehata N. Follicular output rate can predict clinical pregnancy in women with unexplained infertility undergoing IVF/ICSI: a prospective cohort study. Reprod BioMed Online. 2017; doi:10.1016/j.rbmo.2017.03.004. Hassan A, Kotb M, Awadallah A, Wahba A, Shehata N. Follicular output rate can predict clinical pregnancy in women with unexplained infertility undergoing IVF/ICSI: a prospective cohort study. Reprod BioMed Online. 2017; doi:10.​1016/​j.​rbmo.​2017.​03.​004.
11.
go back to reference Li HW, Lee VC, Ho PC, Ng EH. Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment. J Assist Reprod Genet. 2014;31(2):199–203.CrossRefPubMed Li HW, Lee VC, Ho PC, Ng EH. Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment. J Assist Reprod Genet. 2014;31(2):199–203.CrossRefPubMed
12.
go back to reference Huber M, Hadziosmanovic N, Berglund L, Holte J. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone agonist protocol: suggestions for a new principle to solve an old problem. Fertil Steril. 2013;100(5):1270–6.CrossRefPubMed Huber M, Hadziosmanovic N, Berglund L, Holte J. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone agonist protocol: suggestions for a new principle to solve an old problem. Fertil Steril. 2013;100(5):1270–6.CrossRefPubMed
13.
go back to reference Rouzi AA, Ardawi MS. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2006;85:428–35.CrossRefPubMed Rouzi AA, Ardawi MS. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2006;85:428–35.CrossRefPubMed
14.
go back to reference Cooper TG, Noonan E, Von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–45.CrossRefPubMed Cooper TG, Noonan E, Von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–45.CrossRefPubMed
15.
go back to reference Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24.CrossRefPubMed Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24.CrossRefPubMed
16.
go back to reference National Institute for Health and Care Excellence. Fertility: assessment and treatment for people with fertility problems. NICE CG55. London: National Institute for Health and Care Excellence; 2013. National Institute for Health and Care Excellence. Fertility: assessment and treatment for people with fertility problems. NICE CG55. London: National Institute for Health and Care Excellence; 2013.
17.
go back to reference Choe SA, Tae JC, Shin MY, Kim HJ, Kim CH, Lee JY, et al. Application of sperm selection using hyaluronic acid binding in intracytoplasmic sperm injection cycles: a sibling oocyte study. J Korean Med Sci. 2012;27:1569–73.CrossRefPubMedPubMedCentral Choe SA, Tae JC, Shin MY, Kim HJ, Kim CH, Lee JY, et al. Application of sperm selection using hyaluronic acid binding in intracytoplasmic sperm injection cycles: a sibling oocyte study. J Korean Med Sci. 2012;27:1569–73.CrossRefPubMedPubMedCentral
18.
go back to reference Kotb MM, Hassan AM, Awadallah AM. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016;200:11–5.CrossRefPubMed Kotb MM, Hassan AM, Awadallah AM. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016;200:11–5.CrossRefPubMed
19.
go back to reference Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod. 2004;19:1544–7.CrossRefPubMed Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod. 2004;19:1544–7.CrossRefPubMed
20.
go back to reference La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2007;22:766–71.CrossRefPubMed La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2007;22:766–71.CrossRefPubMed
21.
go back to reference Nicopoullos JD, Abdalla H. Poor response cycles: when should we cancel? Comparison of outcome between egg collection, intrauterine insemination conversion, and follow-up cycles after abandonment. Fertil Steril. 2011;95:68–71.CrossRefPubMed Nicopoullos JD, Abdalla H. Poor response cycles: when should we cancel? Comparison of outcome between egg collection, intrauterine insemination conversion, and follow-up cycles after abandonment. Fertil Steril. 2011;95:68–71.CrossRefPubMed
Metadata
Title
Follicular sensitivity index (FSI): a novel tool to predict clinical pregnancy rate in IVF/ICSI cycles
Authors
AbdelGany M. A. Hassan
Mohamed M. M. Kotb
Ahmed M. A. AwadAllah
Nesreen A. A. Shehata
Amr Wahba
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 10/2017
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-017-0984-5

Other articles of this Issue 10/2017

Journal of Assisted Reproduction and Genetics 10/2017 Go to the issue